New Investigational Medication for Postherpetic Neuralgia (PHN/Shingles)

This is a 12 week treatment study to evaluate the efficacy of a new medication compared to placebo in lowering pain intensity in patients with PHN.


Major Inclusion/Exclusion Criteria:

  • Ages 18-80
  • Persistant PHN pain for a minimum of 9 months following the onset of a herpes zoster skin rash (shingles)